In patients with COPD with secondary PAH, there is an increase in SA-β-gal staining, p21 and p16 expression in pulmonary vascular smooth muscle cells, compared with patients with COPD without PAH (Noureddine et al, 2011). Here, CDKN2A is linked to pulmonary arterial hypertension.